Voyageur Pharmaceuticals Ltd.

Voyageur Pharmaceuticals Ltd.

VYYRF - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$21.17M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Voyageur Pharmaceuticals Ltd.Voyageur Pharmaceuticals Ltd.-7.1--75%--
$0.00

Current Fair Value

98.3% downside

Overvalued by 98.3% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$21.17 Million
Enterprise Value$19.39 Million
Earnings per Share$-0.02
Beta0.29
Outstanding Shares223,795,260

Return

Return on Equity-74.81%ROE
Return on Assets-63.25%
Return on Invested Capital-74.86%

Valuation & Multiples

P/E Ratio-7.1P/E Ratio
PEG21.87PEG
Price to Sales-Price to Sales
Price to Book Ratio-Price to Book Ratio
Enterprise Value to Revenue380.03
Enterprise Value to EBIT-6.12
Enterprise Value to Net Income-7
Total Debt to Enterprise0
Debt to Equity0.01Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
November 2, 2026
EPS
-$0.00
Reported
Revenue
$10,669
Reported

Next Earnings Call

Expected Date
April 1, 2027
EPS Estimate
-
Consensus analyst estimate
Revenue Estimate
-
Consensus analyst estimate

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Voyageur Pharmaceuticals Ltd.

49 employees
CEO: Brent Willis

Voyageur Pharmaceuticals Ltd. specializes in the creation of mineral-based active pharmaceutical ingredients (APIs). The company aims to produce radiocontrast agents utilizing barium and iodine, along with pharmaceutical products derived...